Pharmaceutical Technology
Takeda and Innovent fulfil close conditions for ADC and IO therapies
📈
AI Sentiment
Highly Positive
8/10
Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of) News
Latest updates and market news for TAK
4 news
Nov 29 - Dec 5, 2025
Page 1
PR Newswire
Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda for Next-Generation IO and ADC Therapies
📈
AI Sentiment
Highly Positive
8/10
Business Wire
insitro Appoints R&D Veteran Stephen Hitchcock and AI Visionary Vijay Pande as Scientific Advisors
📈
AI Sentiment
Highly Positive
8/10
PR Newswire
Narcolepsy Market is Projected to Grow at a CAGR of 5.6% During the Forecast Period (2025-2034) Due to Increasing Disease Awareness, Improved Diagnosis, and Expanding Therapeutic Options | DelveInsight
📈
AI Sentiment
Highly Positive
8/10
Share this news page